当前位置:
编号:1972653
高密度脂蛋白亚型与心脑血管病发生风险相关性的Meta分析
http://www.100md.com 2020年4月11日 《中国当代医药》 2020年第4期
     [17]Tian L,Fu M.The relationship between high density lipoprotein subclass profile and plasma lipids concentrations[J].Lipids Health Dis,2010,9:118.

    [18]Lagos KG,Filippatos TD,Tsimihodimos V,et al.Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome[J].Lipids,2009,44(1):9-16.

    [19]Calabresi L,Gomaraschi M,Franceschini G.High-density lipoprotein quantity or quality for cardiovascular prevention?[J].Curr Pharm Des,2010,16(13):1494-1503.

    [20]Berger JS,Mcginn AP,Howard BV,et al.Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women[J].Stroke,2012,43(4):958-966.

    [21]Tanne D,Yaari S,Goldbourt U.High-density lipoprotein cholesterol and risk of ischemic stroke mortality.A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study[J].Stroke,1997,28(1):83-87.

    [22]Shah AS,Tan L,Long JL,et al.Proteomic diversity of high density lipoproteins:our emerging understanding of its importance in lipid transport and beyond[J].J Lipid Res,2013,54(10):2575-2585.

    (收稿日期:2019-10-12 本文編辑:任秀兰), 百拇医药(李庆生 王金兰 张俊俊)